Cell-Free DNA (cfDNA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062747
  • May 2021
  • Biotechnology
  • 132 Pages
The global Cell-Free DNA (cfDNA) Testing market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Cell-Free DNA (cfDNA) Testing market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Cell-Free DNA (cfDNA) Testing market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Cell-Free DNA (cfDNA) Testing market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Agilent Technology, Allenex AB, Biocept, Inc., Biodesix, Inc., CareDx, Inc., Guardant Health, Inc., Illumania, Inc., Inivated Limited, Natera, Inc., Quest Diagnostics, Roche Holdings AG, Sequenom, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Cell-Free DNA (cfDNA) Testing market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Cell-Free DNA (cfDNA) Testing market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Cell-Free DNA (cfDNA) Testing market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Cell-Free DNA (cfDNA) Testing market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Cell-Free DNA (cfDNA) Testing Market:
The Cell-Free DNA (cfDNA) Testing market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Agilent Technology, Allenex AB, Biocept, Inc., Biodesix, Inc., CareDx, Inc., Guardant Health, Inc., Illumania, Inc., Inivated Limited, Natera, Inc., Quest Diagnostics, Roche Holdings AG, Sequenom, Inc.

Cell-Free DNA (cfDNA) Testing Market Segment Analysis:
by Type
donor derived cell free DNA
ddcfDNA
circulating cell-free tumor DNA
ctDNA
cell-free fetal DNA
NIPT
Application
oncology
gynecology
transplantation

Geographic Coverage for Cell-Free DNA (cfDNA) Testing Market:
The market research report on global Cell-Free DNA (cfDNA) Testing market offers complete analysis across various regions across the world. The Cell-Free DNA (cfDNA) Testing market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Cell-Free DNA (cfDNA) Testing market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Cell-Free DNA (cfDNA) Testing Market Value and Forecast
  • US
  • Canada
Europe Cell-Free DNA (cfDNA) Testing Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Cell-Free DNA (cfDNA) Testing Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Cell-Free DNA (cfDNA) Testing Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Cell-Free DNA (cfDNA) Testing market report:
  • The report provides key trends of the global Cell-Free DNA (cfDNA) Testing market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Cell-Free DNA (cfDNA) Testing industry
  • The report covers all the recent developments of the Cell-Free DNA (cfDNA) Testing market and helps to provide current industry updates
  • The report covers a detailed look over the global Cell-Free DNA (cfDNA) Testing Industry and provides with significant actionable insights
  • The Cell-Free DNA (cfDNA) Testing market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Cell-Free DNA (cfDNA) Testing market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Cell-Free DNA (cfDNA) Testing market
  • Comprehensive analysis of the Cell-Free DNA (cfDNA) Testing market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Cell-Free DNA (cfDNA) Testing market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Cell-Free DNA (cfDNA) Testing market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Cell-Free DNA (cfDNA) Testing market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Cell-Free DNA (cfDNA) Testing market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Cell-Free DNA (cfDNA) Testing market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Agilent Technology
  • Allenex AB
  • Biocept, Inc.
  • Biodesix, Inc.
  • CareDx, Inc.
  • Guardant Health, Inc.
  • Illumania, Inc.
  • Inivated Limited, Natera, Inc.
  • Quest Diagnostics
  • Roche Holdings AG
  • Sequenom, Inc.
  • donor derived cell free DNA
  • ddcfDNA
  • oncology
  • gynecology
  • transplantation

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Cell-Free DNA (cfDNA) Testing Market Snapshot
          2.1.1. Global Cell-Free DNA (cfDNA) Testing Market By Type,2019
               2.1.1.1.donor derived cell free DNA
               2.1.1.2.ddcfDNA
          2.1.2. Global Cell-Free DNA (cfDNA) Testing Market By Application,2019
               2.1.2.1.oncology
               2.1.2.2.gynecology
               2.1.2.3.transplantation
          2.1.3. Global Cell-Free DNA (cfDNA) Testing Market By End-use,2019
          2.1.4. Global Cell-Free DNA (cfDNA) Testing Market By Geography,2019

3. Global Cell-Free DNA (cfDNA) Testing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028

5. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028

6. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028

7. Global Cell-Free DNA (cfDNA) Testing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Cell-Free DNA (cfDNA) Testing Market Analysis, 2018 – 2028 
          7.2.1. North America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Cell-Free DNA (cfDNA) Testing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Cell-Free DNA (cfDNA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Cell-Free DNA (cfDNA) Testing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Cell-Free DNA (cfDNA) Testing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Cell-Free DNA (cfDNA) Testing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Cell-Free DNA (cfDNA) Testing Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Cell-Free DNA (cfDNA) Testing Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Cell-Free DNA (cfDNA) Testing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Cell-Free DNA (cfDNA) Testing Providers
        8.4.1 Agilent Technology
                8.4.1.1 Business Description
                8.4.1.2 Agilent Technology Geographic Operations
                8.4.1.3 Agilent Technology Financial Information
                8.4.1.4 Agilent Technology Product Positions/Portfolio
                8.4.1.5 Agilent Technology Key Developments
        8.4.2 Allenex AB
                8.4.2.1 Business Description
                8.4.2.2 Allenex AB Geographic Operations
                8.4.2.3 Allenex AB Financial Information
                8.4.2.4 Allenex AB Product Positions/Portfolio
                8.4.2.5 Allenex AB Key Developments
        8.4.3 Biocept, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Biocept, Inc. Geographic Operations
                8.4.3.3 Biocept, Inc. Financial Information
                8.4.3.4 Biocept, Inc. Product Positions/Portfolio
                8.4.3.5 Biocept, Inc. Key Developments
        8.4.4 Biodesix, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Biodesix, Inc. Geographic Operations
                8.4.4.3 Biodesix, Inc. Financial Information
                8.4.4.4 Biodesix, Inc. Product Positions/Portfolio
                8.4.4.5 Biodesix, Inc. Key Developments
        8.4.5 CareDx, Inc.
                8.4.5.1 Business Description
                8.4.5.2 CareDx, Inc. Geographic Operations
                8.4.5.3 CareDx, Inc. Financial Information
                8.4.5.4 CareDx, Inc. Product Positions/Portfolio
                8.4.5.5 CareDx, Inc. Key Developments
        8.4.6 Guardant Health, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Guardant Health, Inc. Geographic Operations
                8.4.6.3 Guardant Health, Inc. Financial Information
                8.4.6.4 Guardant Health, Inc. Product Positions/Portfolio
                8.4.6.5 Guardant Health, Inc. Key Developments
        8.4.7 Illumania, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Illumania, Inc. Geographic Operations
                8.4.7.3 Illumania, Inc. Financial Information
                8.4.7.4 Illumania, Inc. Product Positions/Portfolio
                8.4.7.5 Illumania, Inc. Key Developments
        8.4.8 Inivated Limited, Natera, Inc.
                8.4.8.1 Business Description
                8.4.8.2 Inivated Limited, Natera, Inc. Geographic Operations
                8.4.8.3 Inivated Limited, Natera, Inc. Financial Information
                8.4.8.4 Inivated Limited, Natera, Inc. Product Positions/Portfolio
                8.4.8.5 Inivated Limited, Natera, Inc. Key Developments
        8.4.9 Quest Diagnostics
                8.4.9.1 Business Description
                8.4.9.2 Quest Diagnostics Geographic Operations
                8.4.9.3 Quest Diagnostics Financial Information
                8.4.9.4 Quest Diagnostics Product Positions/Portfolio
                8.4.9.5 Quest Diagnostics Key Developments
        8.4.10 Roche Holdings AG
                8.4.10.1 Business Description
                8.4.10.2 Roche Holdings AG Geographic Operations
                8.4.10.3 Roche Holdings AG Financial Information
                8.4.10.4 Roche Holdings AG Product Positions/Portfolio
                8.4.10.5 Roche Holdings AG Key Developments
        8.4.11 Sequenom, Inc.
                8.4.11.1 Business Description
                8.4.11.2 Sequenom, Inc. Geographic Operations
                8.4.11.3 Sequenom, Inc. Financial Information
                8.4.11.4 Sequenom, Inc. Product Positions/Portfolio
                8.4.11.5 Sequenom, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell-Free DNA (cfDNA) Testing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Cell-Free DNA (cfDNA) Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Cell-Free DNA (cfDNA) Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Cell-Free DNA (cfDNA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Cell-Free DNA (cfDNA) Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Cell-Free DNA (cfDNA) Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Cell-Free DNA (cfDNA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Cell-Free DNA (cfDNA) Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Cell-Free DNA (cfDNA) Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Cell-Free DNA (cfDNA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Cell-Free DNA (cfDNA) Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Cell-Free DNA (cfDNA) Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Cell-Free DNA (cfDNA) Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Cell-Free DNA (cfDNA) Testing: Market Segmentation 
FIG. 2 Global Cell-Free DNA (cfDNA) Testing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Cell-Free DNA (cfDNA) Testing Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Cell-Free DNA (cfDNA) Testing Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Cell-Free DNA (cfDNA) Testing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Cell-Free DNA (cfDNA) Testing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Cell-Free DNA (cfDNA) Testing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Cell-Free DNA (cfDNA) Testing Providers, 2019
FIG. 11 Global Cell-Free DNA (cfDNA) Testing Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Cell-Free DNA (cfDNA) Testing Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Cell-Free DNA (cfDNA) Testing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Cell-Free DNA (cfDNA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Cell-Free DNA (cfDNA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Cell-Free DNA (cfDNA) Testing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Cell-Free DNA (cfDNA) Testing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Cell-Free DNA (cfDNA) Testing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Cell-Free DNA (cfDNA) Testing Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Cell-Free DNA (cfDNA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  North America Cell-Free DNA (cfDNA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  North America Cell-Free DNA (cfDNA) Testing Market Value, By Country, 2018 – 2028
TABLE  Europe Cell-Free DNA (cfDNA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Europe Cell-Free DNA (cfDNA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Europe Cell-Free DNA (cfDNA) Testing Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Cell-Free DNA (cfDNA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Cell-Free DNA (cfDNA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Cell-Free DNA (cfDNA) Testing Market Value, By Country, 2018 – 2028
TABLE  Latin America Cell-Free DNA (cfDNA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Cell-Free DNA (cfDNA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Cell-Free DNA (cfDNA) Testing Market Value, By Country, 2018 – 2028
TABLE  MEA Cell-Free DNA (cfDNA) Testing Market Value, By Segment1, 2018 – 2028
TABLE  MEA Cell-Free DNA (cfDNA) Testing Market Value, By Segment2, 2018 – 2028
TABLE  MEA Cell-Free DNA (cfDNA) Testing Market Value, By Country, 2018 – 2028
TABLE  Agilent Technology: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allenex AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocept, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biodesix, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CareDx, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Guardant Health, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Illumania, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Inivated Limited, Natera, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quest Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche Holdings AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sequenom, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Cell-Free DNA (cfDNA) Testing Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Cell-Free DNA (cfDNA) Testing Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Cell-Free DNA (cfDNA) Testing Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Cell-Free DNA (cfDNA) Testing Market, By Geography, 2019 (US$ Mn)
FIG.  Global Cell-Free DNA (cfDNA) Testing Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Cell-Free DNA (cfDNA) Testing Providers, 2016
FIG.  Global Cell-Free DNA (cfDNA) Testing Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global ddcfDNA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cell-Free DNA (cfDNA) Testing Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global gynecology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global transplantation Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Cell-Free DNA (cfDNA) Testing Market Value, 2018 – 2028, (US$ Mn)